EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1

Historical Holders from Q4 2014 to Q4 2017

Type / Class
Debt / NOTE 2.875% 1/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2017 Q4 $0 $0 -$308,628,161 0
2017 Q3 $214,385,363 $308,628,161 +$44,874 144.12% 27
2017 Q2 $219,175,859 $283,130,913 +$3,581,815 129.29% 24
2017 Q1 $217,075,867 $259,382,431 -$17,823,169 119.5% 25
2016 Q4 $229,679,898 $293,411,749 -$23,255,011 127.59% 27
2016 Q3 $246,559,034 $305,508,159 +$9,514,792 122.81% 32
2016 Q2 $221,501,890 $251,307,146 -$7,655,177 113.43% 34
2016 Q1 $237,209,005 $308,020,766 -$817,183,360 130.03% 34
2015 Q4 $236,667,779 $1,138,303,069 -$30,325,394 137.81% 30
2015 Q3 $230,065,336 $260,805,850 +$39,921,026 113.43% 32
2015 Q2 $183,906,988 $228,027,350 +$34,643,556 123.88% 25
2015 Q1 $155,973,674 $181,055,775 +$170,695,648 115.81% 23
2014 Q4 $8,894,000 $10,011,000 +$10,011,000 112.56% 1